Herum, K. M., Romaine, A., Wang, A., Melleby, A. O., Strand, M. E., Pacheco, J., et al. (2020). Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin. Journal Of The American Heart Association, 9(3), e013518. https://doi.org/10.1161/JAHA.119.013518(Original work published 2020)
Lunde, I. G., Aronsen, J. M., Melleby, A. O., Strand, M. E., Skogestad, J., Bendiksen, B. A., et al. (2022). Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy. Molecular Biology Reports. https://doi.org/10.1007/s11033-022-07985-y(Original work published 2022)
